成纤维细胞生长因子21与肾功能及白蛋白尿的关联:多民族动脉粥样硬化研究
在多民族动脉粥样硬化研究(MESA)的5724名无临床心血管病成人中,基线血浆FGF21水平较高与横断面上较低的eGFR和较高的UACR独立相关,但纵向分析未发现基线FGF21能预测eGFR定义的CKD发生、肾功能快速下降或UACR进展。
要点
- 横断面分析中,最高FGF21四分位组比最低组eGFR低2.63 mL/min/1.73 m2,log UACR高0.134 mg/g。
- 纵向随访10年,基线FGF21未预测eGFR定义的CKD发生、肾功能快速下降或UACR进展。
- FGF21与肾脏结局的关联未受性别或种族/民族显著修饰(交互P>0.05)。
核心结论
- 本研究不支持FGF21作为预测无临床心血管病成人肾功能下降或白蛋白尿的生物标志物。
研究设计与样本
- 多民族动脉粥样硬化研究(MESA)纳入5724名45-84岁、无临床心血管病的参与者,2000-2002年基线检测血浆FGF21,并随访10年。
主要发现
- 横断面分析中,最高FGF21四分位组比最低组eGFR低2.63 mL/min/1.73 m2,log转换的UACR高0.134 mg/g(均P<0.001)。
- 纵向分析中,基线FGF21水平未预测eGFR定义的CKD发生、肾功能快速下降(eGFR年下降>5%)或UACR进展。
- FGF21与结局的关联未发现与性别和种族/民族有显著交互作用(均P>0.05)。
关键数值与推荐
- CKD by eGFR定义为eGFR<60 mL/min/1.73 m2且eGFR年下降速率≥1 mL/min/1.73 m2。
- 肾功能快速下降定义为eGFR年下降>5%。
临床怎么用
- 目前证据不支持将血浆FGF21用于无临床心血管病成人的肾功能下降或白蛋白尿风险预测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fibroblast growth factor 21 (FGF21) may play a role in the development of chronic kidney disease (CKD). We therefore investigated the relationship of plasma FGF21 levels with kidney function and albuminuria in the Multi-Ethnic Study of Atherosclerosis (MESA). METHODS: The analysis included 5724 MESA participants ages 45-84 years between 2000 and 2002, free of clinically apparent cardiovascular disease (CVD). Participants were followed up in person at four additional clinic visits over 10 years. Plasma FGF21 levels were measured at baseline examination by enzyme-linked immunosorbent assay. Kidney function was assessed by estimated glomerular filtration rate (eGFR). Outcomes were urinary albumin:creatinine ratio (UACR) progression, incident CKD by eGFR (reaching eGFR <60 mL/min/1.73 m2 with eGFR loss rate ≥1 mL/min/1.73 m2 per year) and rapid kidney function decline (eGFR decline >5%/year). RESULTS: At baseline, higher FGF21 levels, assessed as both continuous and categorical quartile variables, were significantly associated with lower eGFR and higher UACR, after adjusting for demographic, socioeconomic and other confounding factors [adjusted mean differences of -2.63 mL/min/1.73 m2 in eGFR and 0.134 in log normally transformed UACR (mg/g) for the highest FGF21 quartile compared with the lowest quartile, all P < 0.001]. However, in longitudinal analyses, baseline FGF21 levels did not predict incident CKD by eGFR, rapid kidney function decline or UACR progression. No significant interaction with sex and race/ethnicity was found (all P > 0.05). CONCLUSIONS: Our study does not support a role of FGF21 as a biomarker for predicting kidney function decline or albuminuria in adults free of clinically apparent CVD at baseline.
引用
- Anuwatmatee S, Allison MA, Shlipak MG, et al. Relationship of fibroblast growth factor 21 with kidney function and albuminuria: multi-ethnic study of atherosclerosis. Nephrol Dial Transplant. 2019. PMID: 29771383. doi:10.1093/ndt/gfy120
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。